RMTG — Regenerative Medical Technology Group Inc.
—
OTC ·
Consumer Discretionary ·
Specialty Retail ·
CIK 1760026 ·
Last close
$0.06
Market Cap
$885.9K
52W High
$0.12
52W Low
$0.02
ADV30
76,060
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 4,022,763 | 2,578,171 | 565,977 | -2,905,473 | 5,850,003 | 1,323,304 | 45,105,519 |
| Mar 2026 | 2,639,353 | 1,766,491 | 229,783 | -876,274 | 5,009,582 | 1,061,448 | 40,630,891 |
| Dec 2025 | 1,571,922 | 779,495 | -306,274 | -1,392,843 | 4,488,694 | 956,718 | 39,233,729 |
| Sep 2025 | 1,180,534 | 501,557 | -445,761 | -4,353,741 | 4,519,827 | 1,185,695 | 34,574,268 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-661,504
Investing CF
$-917,977
Financing CF
$1,418,000
CapEx
$-857,395
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.58
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-76,241,785
Inventory
$298,201
Receivables
$34,821
ST Investments
—
EBIT TTM
$815,834
Pretax Income TTM
$-7,928,645
Interest Exp TTM
$8,744,479
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$9,414,572
EBITDA
$493,150
Free Cash Flow
$5,949,599
Enterprise Value
$21,653,268
Total Cash
$1,323,304
Total Debt
$21,740,378
Shares Out
13,738,968
Trailing EPS
$-0.68
Book Value
$-2.86
ROE
—
ROA
1.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 5,100,315 | -867,162 | -7,812,409 | 4,488,694 | 39,233,729 | -34,745,035 | -706,519 |
| Dec 2024 | 4,107,494 | 81,181 | -5,562,971 | 3,821,429 | 31,178,102 | -27,356,673 | 850,699 |
| Dec 2023 | 2,409,953 | -715,227 | -9,813,666 | 2,879,103 | 24,674,606 | -21,795,503 | -419,199 |
| Dec 2022 | 1,530,223 | -1,184,859 | -5,506,822 | 8,080,273 | 20,062,565 | -11,982,292 | -1,114,136 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SNBH | SENTIENT BRANDS HOLDINGS INC. | $1.39M | $0.36 | — |
| NSTM | NovelStem International Corp. | $493.3K | $0.01 | — |
| FBCD | FBC Holding, Inc. | $1.78M | $0.00 | — |
| KXIN | Kaixin Holdings | $2.14M | $1.42 | — |
| JEM | 707 Cayman Holdings Ltd. | $2.42M | $3.79 | — |
News headlines (Yahoo Finance, 1h cache)
RMTG's ISSCA Division to Host ISSCA 125 Global Summit in Cancún, Mexico
2026-09-21 11:01 · Yahoo
RMTG's ISSCA Division Launches Integrative Fellowship in Point-of-Care Regenerative Medicine through ISSCA AI(TM) Strategy
2026-09-17 11:02 · Yahoo
Regenerative Medical Technology Group, Inc. Details Expanded ISSCA AI(TM) Clinical Intelligence Platform, Including Protocol-Native Engine, Structured Data Assets, and Multi-Line Commercial Model
2026-09-14 11:01 · Yahoo
RMTG's Cellgenic Division Begins Local Commercial Activity in Colombia, Subject to Colombian Regulatory Requirements
2026-09-08 11:02 · Yahoo
RMTG's Cellgenic Commences Commercial Activity in Peru, Extending Its Latin American Footprint
2026-09-01 11:01 · Yahoo
RMTG's Cellgenic Division Introduces MUSE Cell Product Line Across Four International Regions
2026-08-27 11:01 · Yahoo
RMTG Acquires RMTG.com Domain and Launches New Investor-Focused Website, Advancing Shareholder Engagement
2026-08-26 11:02 · Yahoo
Global Stem Cells Group (OTC:RMTG) Launches ISSCA Mobile App, Advancing Its Buildout of a Global Digital Ecosystem for Regenerative Medicine
2026-06-17 11:01 · Yahoo
RMTG More Than Quadruples Revenue and Gross Profit in Q2 2026 Versus Q2 2025, With Operating Income Surpassing $560,000
2026-08-20 11:01 · Yahoo
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
2026-08-19 23:25 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.